Phase II, double blind, intermittent dose, placebo controlled, randomised, two period crossover study to investigate the effect of inhaled doses of VR776 administered via Aspirair inhaler on IVELT (intravaginal ejaculatory latency time) measured by stop watch in male patients with premature ejaculation.

Trial Profile

Phase II, double blind, intermittent dose, placebo controlled, randomised, two period crossover study to investigate the effect of inhaled doses of VR776 administered via Aspirair inhaler on IVELT (intravaginal ejaculatory latency time) measured by stop watch in male patients with premature ejaculation.

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Jul 2016

At a glance

  • Drugs Clomipramine (Primary)
  • Indications Premature ejaculation
  • Focus Therapeutic Use
  • Sponsors Vectura
  • Most Recent Events

    • 20 Jul 2016 Status changed from active, no longer recruiting to completed.
    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top